ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Main Author: | R.T. Saygitov |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-08-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Similar Items
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
by: R.T. Saygitov
Published: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
by: Cardile S, et al.
Published: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
by: Yu. V. Yevsyutina
Published: (2018-08-01) -
Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
by: Mingxing HOU, et al.
Published: (2020-11-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
by: Gold Benjamin D, et al.
Published: (2009-11-01)